Skip to Content
주식/증권 📈 긍정적

Merck Stock Rises as Wall Street Looks Past Earnings Guidance Cut to Oncology Strength

요약

The drugmaker posts a narrower-than-expected quarterly loss fueled by growth in its oncology segment.